Inside-Filings
Projekt anfragen

GoodRx Holdings, Inc. (GDRX)

GoodRx Holdings, Inc.
Healthcare · Medical - Healthcare Information Services
TickerGDRXBörseNasdaq
ISINUS38246G1085CIK0001809519
2,65
Schluss · 12.06.2026
1T+0,8 %1W+0,0 %1M+1,5 %3M+18,3 %6M−6,0 %1J−40,8 %
GCS 46 → +0,0
TSI 6,1 · 12,0 ▼ 04.06.
8-K 5.02 24.04.26· 51T
Insider ▼ 15.10.25· 242T
PDF

Glück Conviction Score™ ⓘ

GDRX GoodRx Holdings, Inc.
ⓘ Eingeschränkte Aussagekraft — erst 66 % der Signal-Gewichte sind mit Daten unterlegt.
Conviction Score
46
Neutral
Effektiv: Neutral Niedrig
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
63,3
34 neu, 59 erhöht, -110535K $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)

Score-Verlauf (90 Tage)

Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.

Kursverlauf (12 Monate)

Technische Indikatoren

50
Technical-Score: 50 / 100 (informativ, keine Anlageempfehlung)
Bullisch-Anteil 27.3 % — 3 bullisch / 2 bärisch / 6 neutral

Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).

IndikatorSignalGewichtWertDetailBeitrag
Kurs vs SMA50Bullisch10 %2.51+5.5 % vs SMA50
Kurs vs SMA200Bärisch15 %2.91-8.8 % vs SMA200
EMA20 vs EMA50Bullisch5 %2.69EMA50: 2.57
MACD-HistogrammBärisch10 %-0.040Bearisch
RSI(14)Neutral10 %49.6Neutral (30–70)
Stoch %K(14)Neutral5 %26.6Neutral
ADX(14)+DINeutral10 %20.6+DI: 23.6 / −DI: 21.2
Z-Score(60)Neutral5 %0.72In Range
52W-PositionNeutral5 %24.0 %Hoch 5.12 / Tief 1.87
Bollinger(20,2σ)Neutral5 %41.8 %Upper 3.06 / Mid 2.71 / Lower 2.35
LinReg-Slope(60)Bullisch10 %+0.0154R²=0.77 / annualisiert +159.1 %

Insider-Transaktionen (12 Monate) ⓘ

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2025-10-15Spectrum Equity VII, L.P.10% OwnerOpen Market Sale-8.5694,00-34.282,86-97,4%
2025-10-15Spectrum Equity VII, L.P.10% OwnerOpen Market Sale-15.2024,00-60.820,16-172,8%
2025-09-05Spectrum Equity VII, L.P.10% OwnerOpen Market Sale-5.7734,05-23.380,65-66,4%
2025-09-05Spectrum Equity VII, L.P.10% OwnerOpen Market Sale-10.2434,05-41.484,15-117,9%
2025-07-03Spectrum Equity VII, L.P.10% OwnerOpen Market Sale-3.8494,80-18.466,73-52,5%
2025-07-03Spectrum Equity VII, L.P.10% OwnerOpen Market Sale-6.8284,80-32.759,38-93,1%

Fondsaktivität (Vorquartalsvergleich) ⓘ

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
Francisco Partners Management, LP60.078.18460.078.1840117.753.241Unverändert0,0%
VANGUARD GROUP INC9.584.18309.584.18325.973.136Neu+100,0%
AMERIPRISE FINANCIAL INC4.455.7603.272.4311.183.3298.733.289Aufgestockt+36,2%
VANGUARD CAPITAL MANAGEMENT LLC4.261.51604.261.5168.352.571Neu+100,0%
Silver Lake Group, L.L.C.3.532.2763.532.27606.923.261Unverändert0,0%
RENAISSANCE TECHNOLOGIES LLC3.259.7383.210.93848.8006.389.086Aufgestockt+1,5%
Petrus Trust Company, LTA3.098.5593.098.55906.073.176Unverändert0,0%
DIMENSIONAL FUND ADVISORS LP2.451.1412.650.452-199.3114.803.988Reduziert-7,5%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.2.105.5021.775.502330.0004.126.784Aufgestockt+18,6%
BlackRock, Inc.1.861.5911.980.551-118.9603.648.720Reduziert-6,0%
AQR CAPITAL MANAGEMENT LLC1.802.3451.158.546643.7993.532.596Aufgestockt+55,6%
Technology Crossover Management X, Ltd.1.653.5661.653.56603.240.989Unverändert0,0%
MOORE CAPITAL MANAGEMENT, LP1.529.415938.564590.8512.997.653Aufgestockt+63,0%
Rip Road Capital Partners LP1.055.80701.055.8072.861.237Neu+100,0%
JANE STREET GROUP, LLC1.137.021588.720548.3012.228.562Aufgestockt+93,1%
Pacer Advisors, Inc.808.9240808.9242.192.184Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC1.078.1271.135.563-57.4362.114.064Reduziert-5,1%
GOLDMAN SACHS GROUP INC1.057.9611.701.674-643.7132.073.603Reduziert-37,8%
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.041.563768.728272.8352.041.463Aufgestockt+35,5%
STATE STREET CORP1.011.189976.77334.4161.981.930Aufgestockt+3,5%
DEERFIELD MANAGEMENT COMPANY, L.P.660.1330660.1331.788.960Neu+100,0%
UBS Group AG826.912667.447159.4651.620.748Aufgestockt+23,9%
NANO CAP NEW MILLENNIUM GROWTH FUND L P740.000585.000155.0001.450.400Aufgestockt+26,5%
STIFEL FINANCIAL CORP717.399602.880114.5191.406.101Aufgestockt+19,0%
Universal- Beteiligungs- und Servicegesellschaft mbH676.776734.016-57.2401.326.481Reduziert-7,8%
NORTHERN TRUST CORP655.131394.048261.0831.284.057Aufgestockt+66,3%
Point72 Asset Management, L.P.458.7120458.7121.243.110Neu+100,0%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM575.665575.66501.128.303Unverändert0,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC562.636475.60987.0271.102.767Aufgestockt+18,3%
Assenagon Asset Management S.A.517.576138.030379.5461.014.449Aufgestockt+275,0%
JACOBS LEVY EQUITY MANAGEMENT, INC336.9720336.972913.194Neu+100,0%
VICTORY CAPITAL MANAGEMENT INC408.944547.687-138.743801.530Reduziert-25,3%
Utah Retirement Systems392.614392.6140769.523Unverändert0,0%
CITADEL ADVISORS LLC390.783273.354117.429765.935Aufgestockt+43,0%
BALYASNY ASSET MANAGEMENT L.P.370.310449.032-78.722725.808Reduziert-17,5%
MACKENZIE FINANCIAL CORP348.989375.944-26.955684.018Reduziert-7,2%
Atom Investors LP248.6070248.607673.725Neu+100,0%
MORGAN STANLEY330.2911.118.427-788.136647.372Reduziert-70,5%
D. E. Shaw & Co., Inc.312.128231.74780.381611.771Aufgestockt+34,7%
Graham Capital Management, L.P.224.0730224.073607.238Neu+100,0%
Invesco Ltd.303.507186.534116.973594.873Aufgestockt+62,7%
WELLS FARGO & COMPANY/MN303.307164.289139.018594.482Aufgestockt+84,6%
VIRGINIA RETIREMENT SYSTEMS ET Al184.9500184.950501.215Neu+100,0%
Connor, Clark & Lunn Investment Management Ltd.241.5481.397.551-1.156.003473.434Reduziert-82,7%
Allianz Asset Management GmbH231.177231.1770453.107Unverändert0,0%
Verition Fund Management LLC165.7000165.700449.047Neu+100,0%
TEACHER RETIREMENT SYSTEM OF TEXAS162.1170162.117439.338Neu+100,0%
VARCOV Co.221.782223.794-2.012434.693Reduziert-0,9%
STEINBERGANNA WEALTH MANAGEMENT220.58178.819141.762432.339Aufgestockt+179,9%
XTX Topco Ltd219.40867.338152.070430.040Aufgestockt+225,8%

Top-Fondshalter (Stand: 31.03.2026) ⓘ

FondsAnteileVorquartal (Stk)ΔWert (USD)Anteil (%)
Francisco Partners Management, LP60.078.18460.078.1840,0%117.753.24155,18
AMERIPRISE FINANCIAL INC4.455.7603.272.431+36,2%8.733.2894,09
VANGUARD CAPITAL MANAGEMENT LLC4.261.5160+100,0%8.352.5713,91
Silver Lake Group, L.L.C.3.532.2763.532.2760,0%6.923.2613,24
RENAISSANCE TECHNOLOGIES LLC3.259.7383.210.938+1,5%6.389.0862,99
Petrus Trust Company, LTA3.098.5593.098.5590,0%6.073.1762,85
DIMENSIONAL FUND ADVISORS LP2.451.1412.650.452-7,5%4.803.9882,25
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.2.105.5021.775.502+18,6%4.126.7841,93
BlackRock, Inc.1.861.5911.980.551-6,0%3.648.7201,71
AQR CAPITAL MANAGEMENT LLC1.802.3451.158.546+55,6%3.532.5961,66
Technology Crossover Management X, Ltd.1.653.5661.653.5660,0%3.240.9891,52
MOORE CAPITAL MANAGEMENT, LP1.529.415938.564+63,0%2.997.6531,40
JANE STREET GROUP, LLC1.137.021588.720+93,1%2.228.5621,04
GEODE CAPITAL MANAGEMENT, LLC1.078.1271.135.563-5,1%2.114.0640,99
GOLDMAN SACHS GROUP INC1.057.9611.701.674-37,8%2.073.6030,97
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.041.563768.728+35,5%2.041.4630,96
STATE STREET CORP1.011.189976.773+3,5%1.981.9300,93
UBS Group AG826.912667.447+23,9%1.620.7480,76
NANO CAP NEW MILLENNIUM GROWTH FUND L P740.000585.000+26,5%1.450.4000,68
STIFEL FINANCIAL CORP717.399602.880+19,0%1.406.1010,66

Halter-Trend (6 Quartale)

PeriodeStatusHalterAnteile (Mio)Wert (Mio $)
31.03.2026✓173122,9230
31.12.2025✓184127,9408
30.09.2025✓162118,9502
30.06.2025✓180121,6598
31.03.2025✓168125,2548
31.12.2024✓168138,5639

Top 10 Neueinsteiger

FondsAnteileWert (USD) ⓘ
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.1.775.5024.811.610
MILLENNIUM MANAGEMENT LLC1.756.2704.759.492
DEERFIELD MANAGEMENT COMPANY, L.P.660.1331.788.960
NANO CAP NEW MILLENNIUM GROWTH FUND L P585.0001.585.350
MACKENZIE FINANCIAL CORP375.9441.009.300
Graham Capital Management, L.P.224.073607.238
VARCOV Co.223.794606.482
Aquatic Capital Management LLC120.297326.005
ExodusPoint Capital Management, LP115.584313.233
Counterpoint Mutual Funds LLC108.364293.666

Top 10 Aufstocker

FondsAnteileΔ Anteile ⓘΔ % ⓘWert (USD) ⓘ
AQR CAPITAL MANAGEMENT LLC1.158.546756.209+188.0 %3.139.660
MORGAN STANLEY1.118.427729.181+187.3 %3.030.940
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM575.665500.365+664.5 %1.560.052
LSV ASSET MANAGEMENT2.825.900471.319+20.0 %7.658
GOLDMAN SACHS GROUP INC1.701.674427.993+33.6 %4.611.536
MOORE CAPITAL MANAGEMENT, LP938.564414.513+79.1 %2.543.508
JANE STREET GROUP, LLC588.720401.193+213.9 %1.595.431
VANGUARD GROUP INC9.584.183376.843+4.1 %25.973.136
VICTORY CAPITAL MANAGEMENT INC547.687307.665+128.2 %1.484.232
SUSQUEHANNA INTERNATIONAL GROUP, LLP768.728297.707+63.2 %2.083.253

Top 10 Verkäufer

FondsAnteileΔ Anteile ⓘΔ % ⓘWert (USD) ⓘ
CITADEL ADVISORS LLC273.354-1.318.444-82.8 %740.789
AMERIPRISE FINANCIAL INC3.272.431-612.728-15.8 %8.868.285
Rip Road Capital Partners LP1.055.807-554.961-34.5 %2.861.237
STATE STREET CORP976.773-479.955-32.9 %2.647.055
TWO SIGMA ADVISERS, LP91.943-429.657-82.4 %249.166
SIMPLEX TRADING, LLC34.065-394.276-92.0 %92.316
TWO SIGMA INVESTMENTS, LP149.573-360.274-70.7 %405.343
JACOBS LEVY EQUITY MANAGEMENT, INC336.972-265.933-44.1 %913.194
RENAISSANCE TECHNOLOGIES LLC3.210.938-258.400-7.4 %8.701.642
BANK OF AMERICA CORP /DE/65.967-223.205-77.2 %178.771

Aktivisten & Großaktionäre (13D/13G) ⓘ

DatumInvestorTypAnteilAktienΔZweck
27.03.2026The Vanguard GroupPassiv (13G/A)Ausstieg0-9,33 pp
30.10.2025The Vanguard GroupPassiv (13G/A)9,33 %9.207.340+1,31 pp
16.10.2025Spectrum Equity VII, L.P.Aktivist (13D/A)Ausstieg0-8,26 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
16.10.2025SEA VII Management, LLCAktivist (13D/A)Ausstieg0-8,28 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
16.10.2025Spectrum VII Co-Investment Fund, L.P.Aktivist (13D/A)Ausstieg0-0,01 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
16.10.2025Spectrum VII Investment Managers' Fund, L.P.Aktivist (13D/A)Ausstieg0-0,01 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
16.10.2025Spectrum Equity Associates VII, L.P.Aktivist (13D/A)Ausstieg0-8,26 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
08.09.2025Spectrum Equity Associates VII, L.P.Aktivist (13D/A)8,26 %8.881.362-4,64 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
08.09.2025Spectrum VII Investment Managers' Fund, L.P.Aktivist (13D/A)0,01 %15.202-0,01 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
08.09.2025SEA VII Management, LLCAktivist (13D/A)8,28 %8.905.133-4,62 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
08.09.2025Spectrum VII Co-Investment Fund, L.P.Aktivist (13D/A)0,01 %8.5690,00 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
08.09.2025Spectrum Equity VII, L.P.Aktivist (13D/A)8,26 %8.881.362-4,64 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
03.07.2025Spectrum Equity Associates VII, L.P.Aktivist (13D/A)12,90 %14.865.346-2,90 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
03.07.2025SEA VII Management, LLCAktivist (13D/A)12,90 %14.905.133-3,00 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
03.07.2025Spectrum VII Co-Investment Fund, L.P.Aktivist (13D/A)0,01 %14.342-0,01 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
03.07.2025Spectrum VII Investment Managers' Fund, L.P.Aktivist (13D/A)0,02 %25.445-0,01 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
03.07.2025Spectrum Equity VII, L.P.Aktivist (13D/A)12,90 %14.865.346-2,90 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
09.06.2025Spectrum VII Investment Managers' Fund, L.P.Aktivist (13D/A)0,03 %32.2730,00 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
09.06.2025Spectrum Equity VII, L.P.Aktivist (13D/A)15,80 %18.854.669-1,80 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
09.06.2025SEA VII Management, LLCAktivist (13D/A)15,90 %18.905.133-1,80 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
09.06.2025Spectrum Equity Associates VII, L.P.Aktivist (13D/A)15,80 %18.854.669-1,80 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
09.06.2025Spectrum VII Co-Investment Fund, L.P.Aktivist (13D/A)0,02 %18.1910,00 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
15.05.2025Columbia Management Investment Advisers, LLCPassiv (13G/A)4,30 %4.632.130Neu
15.05.2025Ameriprise Financial, Inc.Passiv (13G/A)4,30 %4.634.771Neu
14.05.2025David RosenPassiv (13G/A)Ausstieg0-5,57 pp
14.05.2025Rubric Capital Management LPPassiv (13G/A)Ausstieg0-5,57 pp
21.03.2025Idea Men, LLCAktivist (13D/A)29,10 %43.164.171-3,21 ppMarch 2025 Repurchase On March 21, 2025 (the "Closing Date"), pursuant to the previousl…
18.03.2025Idea Men, LLCAktivist (13D/A)32,31 %50.164.171-5,99 ppMarch 2025 Stock Purchase Agreement On March 16, 2025, the Reporting Person and the Iss…
18.03.2025Spectrum Equity VII, L.P.Aktivist (13D/A)17,60 %22.843.992-23,20 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
18.03.2025Spectrum VII Co-Investment Fund, L.P.Aktivist (13D/A)0,02 %22.040-0,08 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
18.03.2025SEA VII Management, LLCAktivist (13D/A)17,70 %22.905.133-23,20 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
18.03.2025Spectrum VII Investment Managers' Fund, L.P.Aktivist (13D/A)0,03 %39.101NeuItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
18.03.2025Spectrum Equity Associates VII, L.P.Aktivist (13D/A)17,60 %22.905.133-23,20 ppItem 4 of the Schedule 13D is hereby amended to include the following at the end thereof…
18.03.2025Francisco Partners Management, L.P.Aktivist (13D/A)36,00 %60.078.184-18,90 ppItem 4 of the Original 13D is hereby amended to include the following at the end thereof…
18.03.2025Francisco Partners IV, L.P.Aktivist (13D/A)24,00 %40.019.294-20,80 ppItem 4 of the Original 13D is hereby amended to include the following at the end thereof…
18.03.2025Francisco Partners IV-A, L.P.Aktivist (13D/A)12,00 %20.058.890-16,90 ppItem 4 of the Original 13D is hereby amended to include the following at the end thereof…
18.03.2025Francisco Partners GP IV Management LimitedAktivist (13D/A)36,00 %60.078.184-18,90 ppItem 4 of the Original 13D is hereby amended to include the following at the end thereof…
18.03.2025Francisco Partners GP IV, L.P.Aktivist (13D/A)36,00 %60.078.184-18,90 ppItem 4 of the Original 13D is hereby amended to include the following at the end thereof…
13.02.2025David RosenPassiv (13G)5,57 %5.804.628+0,82 pp
13.02.2025Rubric Capital Management LPPassiv (13G)5,57 %5.804.628-0,79 pp

Stammdaten

GoodRx Holdings, Inc. stellt über seine Tochterunternehmen Informationen und Tools bereit, die es Verbrauchern ermöglichen, Preise zu vergleichen und bei ihren Verschreibungsarzneimittelkäufen in den Vereinigten Staaten zu sparen. Das Unternehmen betreibt eine Preisvergleichsplattform, die Verbrauchern kuratierte, geografisch relevante Rezeptpreise und Zugang zu ausgehandelten Preisen durch GoodRx-Codes bietet, die verwendet werden, um Geld bei Rezepten in den Vereinigten Staaten zu sparen. Das Unternehmen bietet auch andere Gesundheitsprodukte und Dienstleistungen an, einschließlich Abos, Lösungen für Pharmahersteller und Telemedizin-Dienstleistungen. Es bedient Pharmacy Benefit Manager, die Formulare und Verschreibungstransaktionen verwalten, einschließlich der Festlegung von Preisen zwischen Verbrauchern und Apotheken. Das Unternehmen wurde 2015 gegründet und hat seinen Sitz in Santa Monica, Kalifornien.

Unternehmen & Branche

NameGoodRx Holdings, Inc.
TickerGDRX
CIK0001809519
BoerseNasdaq
SektorHealthcare
IndustrieMedical - Healthcare Information Services
SIC7374 · Services-Computer Processing & Data Preparation

Wertpapier & Kennzahlen

CUSIP38246g108
ISINUS38246G1085
TypCommon Stock
Marktkapitalisierung938,8 Mio. USD
KGV (P/E)29,22
Beta1,54

Bewertung

KBV (P/B)1,52 vs. 16,11 (2021) ▼
KUV (P/S)1,18 vs. 17,97 (2021) ▼
EV/EBITDA7,1 vs. 274,5 (2021) ▼
FCF-Rendite17,5 % vs. 1,3 % (2021) ▲
Buyback-Rendite23,0 % vs. 0,0 % (2021) ▲

Qualität & Bilanz

Operative Marge11,0 % vs. 1,8 % (2021) ▲
Nettomarge3,8 % vs. -3,4 % (2021) ▲
ROIC2,6 % vs. -1,6 % (2021) ▲
Nettoverschuldung/EBITDA1,6 vs. -5,0 (2021) ▲
Zinsdeckungsgrad2,1 vs. 0,6 (2021) ▲

Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →

Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
Kennzahl20212022202320242025Verlauf
Bewertung
KBV (P/B)16,112,363,612,521,57
KUV (P/S)17,972,513,662,301,21
EV/EBITDA274,533,734,614,27,2
FCF-Rendite1,3 %7,4 %5,0 %10,0 %17,0 %
Buyback-Rendite0,0 %5,3 %3,8 %8,7 %22,4 %
Qualität & Bilanz
Operative Marge1,8 %0,2 %-3,6 %8,3 %11,0 %
Nettomarge-3,4 %-4,3 %-1,2 %2,1 %3,8 %
ROIC-1,6 %-2,1 %-0,6 %1,3 %2,6 %
Nettoverschuldung/EBITDA-5,0-0,70,50,71,6
Zinsdeckungsgrad0,60,1-0,51,22,1

Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).

Externe Quelle: SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »

Finanzkennzahlen (SEC XBRL) ⓘ

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2026-03-3110-Q194.006.0001.169.0000,002.021.251.000621.986.000
2025-12-3110-K796.853.00030.439.0000,091.404.058.000616.262.000
2025-09-3010-Q196.028.0001.119.0000,001.325.507.000600.712.000
2025-06-3010-Q203.070.00012.843.0000,041.318.706.000643.031.000
2025-03-3110-Q202.970.00011.052.0000,031.295.271.000654.347.000
2024-12-3110-K792.324.00016.390.0000,041.388.067.000724.658.000
2024-09-3010-Q195.251.0003.965.0000,011.354.846.000696.434.000
2024-06-3010-Q200.610.0006.694.0000,021.475.390.000669.399.000
2024-03-3110-Q197.880.000-1.009.0000,001.453.963.000631.069.000
2023-12-3110-K750.265.000-8.868.000-0,021.588.800.000761.958.000
2023-09-3010-Q179.958.000-38.495.000-0,091.707.972.000881.273.000
2023-06-3010-Q189.677.00058.786.0000,141.692.102.000895.371.000
2023-03-3110-Q183.986.000-3.290.000-0,011.611.500.000827.468.000
2022-12-3110-K766.554.000-32.828.000-0,081.604.631.000814.827.000
2022-09-3010-Q187.318.000-41.734.000-0,101.567.059.000788.403.000
2022-06-3010-Q191.798.000-1.415.0000,001.591.996.000817.940.000
2022-03-3110-Q203.329.00012.293.0000,031.538.328.000786.507.000
2021-12-3110-K745.424.000-25.254.000-0,061.607.625.000831.680.000
2021-09-3010-Q195.102.000-18.069.000-0,041.614.365.000846.396.000
2021-06-3010-Q176.635.00031.061.0000,071.586.929.000824.394.000

Umsatz nach Segmenten & Regionen ⓘ

Geschäftssegmente

SegmentFY 2025FY 2024FY 2023FY 2022FY 2021AnteilΔTrend
Prescription Transactions Revenue544,0 Mio.577,5 Mio.550,7 Mio.550,5 Mio.593,4 Mio.68,3 %-5,8%
Pharma Direct Revenue151,4 Mio.––––19,0 %Neu
Subscription Revenue83,8 Mio.86,5 Mio.94,4 Mio.96,2 Mio.59,9 Mio.10,5 %-3,2%
Other Revenue17,7 Mio.21,0 Mio.20,1 Mio.20,4 Mio.92,1 Mio.2,2 %-15,8%
Pharma Manufacturer Solutions Revenues–107,2 Mio.85,1 Mio.99,4 Mio.–––

Quartalsergebnisse (Earnings) ⓘ

QuartalStichtagVerkündetUmsatzEPS
Q1 202631.03.202606.05.2026194,0 Mio. USD0,00
Q3 202530.09.202504.11.2025196,0 Mio. USD0,00
Q2 202530.06.202504.11.2025203,1 Mio. USD0,04
Q1 202531.03.202506.05.2026203,0 Mio. USD0,03
Q3 202430.09.202404.11.2025195,3 Mio. USD0,01
Q2 202430.06.202404.11.2025200,6 Mio. USD0,02
Q1 202431.03.202404.11.2025197,9 Mio. USD0,00
Q3 202330.09.202307.11.2024180,0 Mio. USD-0,09
Q2 202330.06.202307.11.2024189,7 Mio. USD0,14

Einreichungs-Historie (10-K / 10-Q)

SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte (10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die Tage zwischen Berichtsstichtag und tatsächlicher Einreichung. Suffix /A kennzeichnet nachträgliche Berichtigungen.

Eingereicht Form Berichtsperiode Verzögerung
06.05.2026 10-Q 31.03.2026 36 Tage SEC »
26.02.2026 10-K 31.12.2025 57 Tage SEC »
04.11.2025 10-Q 30.09.2025 35 Tage SEC »
06.08.2025 10-Q 30.06.2025 37 Tage SEC »
07.05.2025 10-Q 31.03.2025 37 Tage SEC »
27.02.2025 10-K 31.12.2024 58 Tage SEC »
07.11.2024 10-Q 30.09.2024 38 Tage SEC »
08.08.2024 10-Q 30.06.2024 39 Tage SEC »
09.05.2024 10-Q 31.03.2024 39 Tage SEC »
29.02.2024 10-K 31.12.2023 60 Tage SEC »
09.11.2023 10-Q 30.09.2023 40 Tage SEC »
09.08.2023 10-Q 30.06.2023 40 Tage SEC »
10.05.2023 10-Q 31.03.2023 40 Tage SEC »
01.03.2023 10-K 31.12.2022 60 Tage SEC »
09.11.2022 10-Q 30.09.2022 40 Tage SEC »
09.08.2022 10-Q 30.06.2022 40 Tage SEC »
10.05.2022 10-Q 31.03.2022 40 Tage SEC »
01.03.2022 10-K 31.12.2021 60 Tage SEC »
12.11.2021 10-Q 30.09.2021 43 Tage SEC »
12.08.2021 10-Q 30.06.2021 43 Tage SEC »
14.05.2021 10-Q 31.03.2021 44 Tage SEC »
12.03.2021 10-K 31.12.2020 71 Tage SEC »
12.11.2020 10-Q 30.09.2020 43 Tage SEC »

Kritische 8-K Meldungen ⓘ

WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (24.04.2026)
HOCH Abgang Schlüsselpersonen (03.04.2026)
HOCH Abgang Schlüsselpersonen (27.03.2026)
DatumMeldungSchwereFilingAuszug
24.04.2026Item 5.02 — Abgang SchlüsselpersonenHOCHSECSection 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors…
03.04.2026Item 5.02 — Abgang SchlüsselpersonenHOCHSECSection 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors…
27.03.2026Item 5.02 — Abgang SchlüsselpersonenHOCHSECSection 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors…
06.03.2026Item 5.02 — Abgang SchlüsselpersonenHOCHSECSection 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors…
27.02.2026Item 5.02 — Abgang SchlüsselpersonenHOCHSECSection 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors…
03.11.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECSection 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors…
22.01.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECSection 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors…
07.03.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSEC13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment…
17.01.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSEC13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment…
06.06.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECListing.   The information set forth in Item 5.02 of this Current Report on Form 8-K is incorporated by reference into…
02.06.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSEC13(a) of the Exchange Act. ☐     Item 5.02 Departure of Directors or Certain Officers; Election of Directors…
25.04.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECexecutive leadership transition described in Item 5.02 of this Current Report on Form 8-K which addresses the Company’s…

Hinweis

Erweitert ×